![]() Antazoline structure
|
Common Name | Antazoline | ||
---|---|---|---|---|
CAS Number | 91-75-8 | Molecular Weight | 265.353 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 475.5±38.0 °C at 760 mmHg | |
Molecular Formula | C17H19N3 | Melting Point | 159ºC | |
MSDS | N/A | Flash Point | 241.4±26.8 °C |
Use of AntazolineAntazoline is an H1 receptor antagonist that affects the activity of the central nervous system, has a potent antiarrhythmic effect[1][2][3]. |
Name | antazoline |
---|---|
Synonym | More Synonyms |
Description | Antazoline is an H1 receptor antagonist that affects the activity of the central nervous system, has a potent antiarrhythmic effect[1][2][3]. |
---|---|
Related Catalog | |
Target |
H1 receptor |
In Vitro | Antazoline shows good inhibitory effect on HBV DNA in the supernatant of HepAD38 and Huh7 cells with the value of EC50 is 2.910 μmol/L and 2.349 μmol/L, respectively[2]. Cell Cytotoxicity Assay[2] Cell Line: HepAD38 cells Concentration: 10μmol/L Incubation Time: 5 days Result: Exhibited no significant cytotoxicity at a concentration of 10μmol/L and had a dose-dependent inhibition of HBV DNA in the supernatant. RT-PCR[2] Cell Line: Huh7 cells Concentration: 30 μmol/L, 10 μmol/L, 3.33 μmol/L, 1.1 μmol/L, 0.370 μmol/L, and 0.123 μmol/L Incubation Time: 4 days Result: Had a significant inhibitory effect on HBV DNA in supernatants in a dose-dependent manner. |
In Vivo | Antazoline (IP; 0.01 ml/g; 30min) as H1 receptor antagonists diminishes the anticonvulsant activity of carbamazepine and diphenylhydantoin[3]. Animal Model: Swiss mice[3] Dosage: 0.01 mL/g Administration: Antazoline (IP; 0.01 ml/g; 30min) Result: Showed some proconvulsive activity. |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 475.5±38.0 °C at 760 mmHg |
Melting Point | 159ºC |
Molecular Formula | C17H19N3 |
Molecular Weight | 265.353 |
Flash Point | 241.4±26.8 °C |
Exact Mass | 265.157898 |
PSA | 27.63000 |
LogP | 4.39 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.608 |
Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Codes | Xi |
---|---|
Safety Phrases | S22-S24/25 |
~78% Antazoline CAS#:91-75-8 |
Literature: Dash; Kudav; Parihar Journal of Heterocyclic Chemistry, 2006 , vol. 43, # 2 p. 401 - 404 |
~% Antazoline CAS#:91-75-8 |
Literature: Helvetica Chimica Acta, , vol. 33, p. 1386,1403 |
~% Antazoline CAS#:91-75-8 |
Literature: DE847746 , ; DRP/DRBP Org.Chem. US2505248 ; |
~% Antazoline CAS#:91-75-8 |
Literature: DE847746 , ; DRP/DRBP Org.Chem. US2505248 ; |
~% Antazoline CAS#:91-75-8 |
Literature: US2505133 , ; |
Phenazoline |
1H-Imidazole-2-methanamine, 4,5-dihydro-N-phenyl-N-(phenylmethyl)- |
Antistin |
Histostab |
Fenazolina |
Phenazolin |
Histazine |
N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)phenylamine |
EINECS 202-094-0 |
Antastan |
Antistine |
Antazoline |
Imidamine |
Antihistal |
N-Benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline |
N-Benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-anilin |
MFCD00047013 |
Antasten |
benzyl-(4,5-dihydro-1H-imidazol-2-ylmethyl)-phenyl-amine |
N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-aniline |
N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-N-(phenylmethyl)aniline |